Weening Michael 4
4 · CALIX, INC · Filed Sep 11, 2025
Insider Transaction Report
Form 4
CALIX, INC(CALX)
Weening Michael
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-09-10−7,990→ 292,010 totalExercise: $7.84Exp: 2029-11-27→ Common Stock (7,990 underlying) - Exercise/Conversion
Common Stock
2025-09-10$7.84/sh+7,990$62,642→ 24,107 total - Exercise/Conversion
Common Stock
2025-09-10$7.84/sh+150,000$1,176,000→ 166,117 total - Sale
Common Stock
2025-09-10$62.00/sh−150,000$9,300,000→ 16,117 total - Sale
Common Stock
2025-09-10$63.00/sh−7,990$503,370→ 16,117 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-10−150,000→ 300,000 totalExercise: $7.84Exp: 2029-11-27→ Common Stock (150,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-09-11−18,010→ 274,000 totalExercise: $7.84Exp: 2029-11-27→ Common Stock (18,010 underlying) - Exercise/Conversion
Common Stock
2025-09-11$7.84/sh+18,010$141,198→ 34,127 total - Sale
Common Stock
2025-09-11$63.00/sh−18,010$1,134,630→ 16,117 total
Footnotes (1)
- [F1]100% of the shares subject to the option were fully vested and exercisable on November 27, 2023.